[1] Tangren J, Nadel M, Hladunewich M A. Pregnancy and end-stage renal disease[J]. Blood Purification, 2018,45(1-3):194-200. [2] Shen Y J, Cai R R, Sun J, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men:A systematic review and meta-analysis[J]. Endocrine, 2017,55(1):66-76. [3] Khan S, Rosner M H. Peritoneal dialysis for patients with end-stage renal disease and liver cirrhosis[J]. Peritoneal Dialysis International, 2018,38(6):397-401. [4] Bansal N. Evolution of cardiovascular disease during the transition to end-stage renal disease[J]. Seminars in Nephrology, 2017,37(2):120-131. [5] Hruska KA, Sugatani T, Agapova O, et al. The chronic kidney disease-mineral bone disorder (ckd-mbd):Advances in pathophysiology[J]. Bone, 2017,100:80-86. [6] Zand L, Kumar R. The use of vitamin d metabolites and analogues in the treatment of chronic kidney disease[J]. Endocrinology and Metabolism Clinics of North America, 2017,46(4):983-1007. [7] Su G B, Liu Z Z, Qin X D, et al. Vitamin D deficiency and treatment versus risk of infection in end-stage renal disease patients under dialysis:A systematic review and meta-analy-sis[J]. Nephrology Dialysis Transplantation, 2018,34(1):146-156. [8] Xu L, Hu X S, Chen W L. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis[J]. Journal of Nephrology, 2019,32(2):307-314. [9] Quarles L D. Fibroblast growth factor 23 and a-Klotho co-dependent and independent functions[J]. Current Opinion in Nephrology and Hypertension, 2019,28(1):16-25. [10] Takashi Y, Fukumoto S. Phosphate-sensing and regulatory mechanism of FGF23 production[J]. Journal of Endocrinological Investigation, 2020,43(7):877-883. [11] 张淑芳, 梁震, 张红梅, 等. 维持性血液透析患者血管钙化危险因素分析[J]. 华北理工大学学报(医学版), 2016,18(4):294-298. [12] Inampudi C, Alvarez P, Asleh R, et al. Therapeutic approach to patients with heart failure with reduced ejection fraction and end-stage renal disease[J]. Current Cardiology Reviews, 2018,14(1):60-66. [13] Jiang Z, Tang Y, Yang L C, et al. Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease:A systematic review and meta-analysis[J]. International Urology and Nephrology, 2018,50(4):687-694. [14] Wald R, Thorpe K E, Walsh M W. Leveraging pragmatic clinical trial design to advance phosphate management in end-stage renal disease[J]. Current Opinion in Nephrology and Hypertension, 2019,28(1):34-39. [15] Edmonston D L, Isakova T, Dember L M, et al. Design and rationale of hilo:A pragmatic, randomized trial of phosphate management for patients receiving maintenance hemodialy-sis[J]. American Journal of Kidney Diseases, 2021,77(6):920-930. [16] Lundquist A L, Nigwekar S U. Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease[J]. Current Opinion in Nephrology and Hypertension, 2016,25(2):120-126. [17] Joshi S, Shah S, Kalantar-Zadeh K. Adequacy of plant-based proteins in chronic kidney disease[J]. Joural of Renal Nutrition, 2019,29(2):112-117. [18] Razaq S, Nigar F, Naqvi S H. Ultrasonographic diagnosis of tumoral calcinosis in end-stage renal disease[J]. Journal of the College of Physicians and Surgeons Pakistan:JCPSP, 2018,28(8):640-642. [19] Block G A, Rosenbaum D P, Yan A, et al. Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis:A randomized phase 3 trial[J]. Journal of the American Society of Nephrology, 2019,30(4):641-652. [20] Voelkl J, Tuffaha R, Luong T T D, et al. Zinc Inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-κB[J]. Journal of the American Society of Nephrology:JASN, 2018,29(6):1636-1648. [21] Milazi M, Douglas C, Bonner A. A bundled phosphate control intervention (4Ds) for adults with end-stage kidney disease receiving haemodialysis:A cluster randomized controlled trial[J]. Journal of Advanced Nursing, 2021,77(3):1345-1356. |